Form D · Biotechnology
Airway Therapeutics, Inc.
Marietta, GA · CIK 0001733867
Offering snapshot reported Sep 9, 2026 · SEC filing
- Reported sold
- $43.5M Offering amount: $50.6M
- Investors reported
- 116 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 10, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2026 | Initial | $43,496,282 | No comparison | 116 | SEC filing |
| Mar 13, 2018 | Initial | $10,930,967 | No comparison | 39 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-596861
Source: Form D, filed Sep 9, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jennifer Dauer | Director |
| Doug Loftus | Director |
| Elise Scroggs Panayotopoulous | Director |
| John M. Rice | Director |
| Marc Salzberg | Director, Executive |
| Joe Todicsco | Director |
| Michael Venerable | Director |
| Alan Wolk | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1205 Johnson Ferry Rd. Suite 136, Box 518
Marietta, GA, 30068
Phone: 513-770-9630
Marietta, GA, 30068
Phone: 513-770-9630